+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Artificial Organs and Bionic Implants Market in Spain 2024-2028

  • PDF Icon

    Report

  • 136 Pages
  • December 2024
  • Region: Spain
  • TechNavio
  • ID: 5547297
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The artificial organs and bionic implants market in spain is forecasted to grow by USD 702.9 million during 2023-2028, accelerating at a CAGR of 12.5% during the forecast period. The report on the artificial organs and bionic implants market in spain provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by scarcity of organ donors, increase in incidence of disabilities and organ failures, and technological advancements in country.

The artificial organs and bionic implants market in spain is segmented as below:

By Product

  • Artificial organs
  • Bionic implants

By End-user

  • Hospital and clinics
  • Specialty centers
  • Others

By Geographical Landscape

  • Europe
This study identifies the increase in medical tourism as one of the prime reasons driving the artificial organs and bionic implants market in spain growth during the next few years. Also, high number of road accidents leading to amputations and rising access to comprehensive medical care will lead to sizable demand in the market.

The report on the artificial organs and bionic implants market in spain covers the following areas:

  • Artificial Organs And Bionic Implants Market in Spain sizing
  • Artificial Organs And Bionic Implants Market in Spain forecast
  • Artificial Organs And Bionic Implants Market in Spain industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial organs and bionic implants market in spain vendors that include Asahi Kasei Corp., Baxter International Inc., Berlin Heart GmbH, Boston Scientific Corp., Edwards Lifesciences Corp., Ekso Bionics Holdings Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Medtronic Plc, Ossur hf, Ottobock SE and Co. KGaA, Sonova AG, Terumo Medical Corp., and Zimmer Biomet Holdings Inc. Also, the artificial organs and bionic implants market in spain analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value Chain Analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
Chart on Spain - Market size and forecast 2023-2028 ($ million)
Data Table on Spain - Market size and forecast 2023-2028 ($ million)
Chart on Spain: Year-over-year growth 2023-2028 (%)
Data Table on Spain: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Artificial Organs And Bionic Implants Market in Spain 2018 - 2022
Historic Market Size - Data Table on Artificial Organs And Bionic Implants Market in Spain 2018 - 2022 ($ million)
5.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
5.3 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Artificial Organs and Bionic Implants Market in Spain
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 Artificial organs - Market size and forecast 2023-2028
Chart on Artificial organs - Market size and forecast 2023-2028 ($ million)
Data Table on Artificial organs - Market size and forecast 2023-2028 ($ million)
Chart on Artificial organs - Year-over-year growth 2023-2028 (%)
Data Table on Artificial organs - Year-over-year growth 2023-2028 (%)
8.4 Bionic implants - Market size and forecast 2023-2028
Chart on Bionic implants - Market size and forecast 2023-2028 ($ million)
Data Table on Bionic implants - Market size and forecast 2023-2028 ($ million)
Chart on Bionic implants - Year-over-year growth 2023-2028 (%)
Data Table on Bionic implants - Year-over-year growth 2023-2028 (%)
8.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Hospital and clinics - Market size and forecast 2023-2028
Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ million)
Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%)
Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%)
9.4 Specialty centers - Market size and forecast 2023-2028
Chart on Specialty centers - Market size and forecast 2023-2028 ($ million)
Data Table on Specialty centers - Market size and forecast 2023-2028 ($ million)
Chart on Specialty centers - Year-over-year growth 2023-2028 (%)
Data Table on Specialty centers - Year-over-year growth 2023-2028 (%)
9.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Drivers, Challenges, and Opportunity/Restraints
11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
11.4 Market opportunities/restraints
12 Competitive Landscape
12.1 Overview
12.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
12.3 Landscape disruption
Overview on factors of disruption
12.4 Industry risks
Impact of key risks on business
13 Competitive Analysis
13.1 Companies profiled
Companies covered
13.2 Company ranking index
Company ranking index
13.3 Market positioning of companies
Matrix on companies position and classification
13.4 Asahi Kasei Corp.
Asahi Kasei Corp. - Overview
Asahi Kasei Corp. - Business segments
Asahi Kasei Corp. - Key news
Asahi Kasei Corp. - Key offerings
Asahi Kasei Corp. - Segment focus
SWOT
13.5 Boston Scientific Corp.
Boston Scientific Corp. - Overview
Boston Scientific Corp. - Business segments
Boston Scientific Corp. - Key news
Boston Scientific Corp. - Key offerings
Boston Scientific Corp. - Segment focus
SWOT
13.6 Edwards Lifesciences Corp.
Edwards Lifesciences Corp. - Overview
Edwards Lifesciences Corp. - Business segments
Edwards Lifesciences Corp. - Key news
Edwards Lifesciences Corp. - Key offerings
Edwards Lifesciences Corp. - Segment focus
SWOT
13.7 Johnson and Johnson Inc.
Johnson and Johnson Inc. - Overview
Johnson and Johnson Inc. - Business segments
Johnson and Johnson Inc. - Key news
Johnson and Johnson Inc. - Key offerings
Johnson and Johnson Inc. - Segment focus
SWOT
13.8 Medtronic Plc
Medtronic Plc - Overview
Medtronic Plc - Business segments
Medtronic Plc - Key news
Medtronic Plc - Key offerings
Medtronic Plc - Segment focus
SWOT
13.9 Ossur hf
Ossur hf - Overview
Ossur hf - Business segments
Ossur hf - Key offerings
Ossur hf - Segment focus
SWOT
13.10 Ottobock SE and Co. KGaA
Ottobock SE and Co. KGaA - Overview
Ottobock SE and Co. KGaA - Product / Service
Ottobock SE and Co. KGaA - Key offerings
SWOT
13.11 Sonova AG
Sonova AG - Overview
Sonova AG - Business segments
Sonova AG - Key offerings
Sonova AG - Segment focus
SWOT
13.12 Terumo Medical Corp.
Terumo Medical Corp. - Overview
Terumo Medical Corp. - Product / Service
Terumo Medical Corp. - Key offerings
SWOT
13.13 Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings Inc. - Overview
Zimmer Biomet Holdings Inc. - Business segments
Zimmer Biomet Holdings Inc. - Key news
Zimmer Biomet Holdings Inc. - Key offerings
Zimmer Biomet Holdings Inc. - Segment focus
SWOT
14 Appendix
14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
14.3 Currency conversion rates for US$
Currency conversion rates for US$
14.4 Research methodology
Research methodology
14.5 Data procurement
Information sources
14.6 Data validation
Data validation
14.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
14.8 Data synthesis
Data synthesis
14.9 360 degree market analysis
360 degree market analysis
14.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Product
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Company Market Positioning
Exhibits 7: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 8: Overview on criticality of inputs and factors of differentiation
Exhibits 9: Overview on factors of disruption
Exhibits 10: Impact of drivers and challenges in 2023 and 2028
Exhibits 11: Parent Market
Exhibits 12: Data Table on - Parent Market
Exhibits 13: Market characteristics analysis
Exhibits 14: Value Chain Analysis
Exhibits 15: Offerings of companies included in the market definition
Exhibits 16: Market segments
Exhibits 17: Chart on Spain - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Data Table on Spain - Market size and forecast 2023-2028 ($ million)
Exhibits 19: Chart on Spain: Year-over-year growth 2023-2028 (%)
Exhibits 20: Data Table on Spain: Year-over-year growth 2023-2028 (%)
Exhibits 21: Historic Market Size - Data Table on Artificial Organs And Bionic Implants Market in Spain 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 24: Five forces analysis - Comparison between 2023 and 2028
Exhibits 25: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 30: Chart on Market condition - Five forces 2023 and 2028
Exhibits 31: Chart on Product - Market share 2023-2028 (%)
Exhibits 32: Data Table on Product - Market share 2023-2028 (%)
Exhibits 33: Chart on Comparison by Product
Exhibits 34: Data Table on Comparison by Product
Exhibits 35: Chart on Artificial organs - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Data Table on Artificial organs - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Chart on Artificial organs - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Artificial organs - Year-over-year growth 2023-2028 (%)
Exhibits 39: Chart on Bionic implants - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Data Table on Bionic implants - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Chart on Bionic implants - Year-over-year growth 2023-2028 (%)
Exhibits 42: Data Table on Bionic implants - Year-over-year growth 2023-2028 (%)
Exhibits 43: Market opportunity by Product ($ million)
Exhibits 44: Data Table on Market opportunity by Product ($ million)
Exhibits 45: Chart on End-user - Market share 2023-2028 (%)
Exhibits 46: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 47: Chart on Comparison by End-user
Exhibits 48: Data Table on Comparison by End-user
Exhibits 49: Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Specialty centers - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Specialty centers - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Specialty centers - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Specialty centers - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 61: Market opportunity by End-user ($ million)
Exhibits 62: Data Table on Market opportunity by End-user ($ million)
Exhibits 63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 64: Impact of drivers and challenges in 2023 and 2028
Exhibits 65: Overview on criticality of inputs and factors of differentiation
Exhibits 66: Overview on factors of disruption
Exhibits 67: Impact of key risks on business
Exhibits 68: Companies covered
Exhibits 69: Company ranking index
Exhibits 70: Matrix on companies position and classification
Exhibits 71: Asahi Kasei Corp. - Overview
Exhibits 72: Asahi Kasei Corp. - Business segments
Exhibits 73: Asahi Kasei Corp. - Key news
Exhibits 74: Asahi Kasei Corp. - Key offerings
Exhibits 75: Asahi Kasei Corp. - Segment focus
Exhibits 76: SWOT
Exhibits 77: Boston Scientific Corp. - Overview
Exhibits 78: Boston Scientific Corp. - Business segments
Exhibits 79: Boston Scientific Corp. - Key news
Exhibits 80: Boston Scientific Corp. - Key offerings
Exhibits 81: Boston Scientific Corp. - Segment focus
Exhibits 82: SWOT
Exhibits 83: Edwards Lifesciences Corp. - Overview
Exhibits 84: Edwards Lifesciences Corp. - Business segments
Exhibits 85: Edwards Lifesciences Corp. - Key news
Exhibits 86: Edwards Lifesciences Corp. - Key offerings
Exhibits 87: Edwards Lifesciences Corp. - Segment focus
Exhibits 88: SWOT
Exhibits 89: Johnson and Johnson Inc. - Overview
Exhibits 90: Johnson and Johnson Inc. - Business segments
Exhibits 91: Johnson and Johnson Inc. - Key news
Exhibits 92: Johnson and Johnson Inc. - Key offerings
Exhibits 93: Johnson and Johnson Inc. - Segment focus
Exhibits 94: SWOT
Exhibits 95: Medtronic Plc - Overview
Exhibits 96: Medtronic Plc - Business segments
Exhibits 97: Medtronic Plc - Key news
Exhibits 98: Medtronic Plc - Key offerings
Exhibits 99: Medtronic Plc - Segment focus
Exhibits 100: SWOT
Exhibits 101: Ossur hf - Overview
Exhibits 102: Ossur hf - Business segments
Exhibits 103: Ossur hf - Key offerings
Exhibits 104: Ossur hf - Segment focus
Exhibits 105: SWOT
Exhibits 106: Ottobock SE and Co. KGaA - Overview
Exhibits 107: Ottobock SE and Co. KGaA - Product / Service
Exhibits 108: Ottobock SE and Co. KGaA - Key offerings
Exhibits 109: SWOT
Exhibits 110: Sonova AG - Overview
Exhibits 111: Sonova AG - Business segments
Exhibits 112: Sonova AG - Key offerings
Exhibits 113: Sonova AG - Segment focus
Exhibits 114: SWOT
Exhibits 115: Terumo Medical Corp. - Overview
Exhibits 116: Terumo Medical Corp. - Product / Service
Exhibits 117: Terumo Medical Corp. - Key offerings
Exhibits 118: SWOT
Exhibits 119: Zimmer Biomet Holdings Inc. - Overview
Exhibits 120: Zimmer Biomet Holdings Inc. - Business segments
Exhibits 121: Zimmer Biomet Holdings Inc. - Key news
Exhibits 122: Zimmer Biomet Holdings Inc. - Key offerings
Exhibits 123: Zimmer Biomet Holdings Inc. - Segment focus
Exhibits 124: SWOT
Exhibits 125: Inclusions checklist
Exhibits 126: Exclusions checklist
Exhibits 127: Currency conversion rates for US$
Exhibits 128: Research methodology
Exhibits 129: Information sources
Exhibits 130: Data validation
Exhibits 131: Validation techniques employed for market sizing
Exhibits 132: Data synthesis
Exhibits 133: 360 degree market analysis
Exhibits 134: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the artificial organs and bionic implants market in spain: Asahi Kasei Corp., Baxter International Inc., Berlin Heart GmbH, Boston Scientific Corp., Edwards Lifesciences Corp., Ekso Bionics Holdings Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Medtronic Plc, Ossur hf, Ottobock SE and Co. KGaA, Sonova AG, Terumo Medical Corp., and Zimmer Biomet Holdings Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in medical tourism."

According to the report, one of the major drivers for this market is the scarcity of organ donors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Asahi Kasei Corp.
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corp.
  • Edwards Lifesciences Corp.
  • Ekso Bionics Holdings Inc.
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson Inc.
  • Medtronic Plc
  • Ossur hf
  • Ottobock SE and Co. KGaA
  • Sonova AG
  • Terumo Medical Corp.
  • Zimmer Biomet Holdings Inc.